News
MiMedx Group
MDXG · NASDAQ
$4.23−$0.15 (−3.42%)TodayMarket closed ·
Prev close $4.38
Latest news
- Press releaseGlobe Newswire
MIMEDX Announces Favorable Federal Court Ruling in AXIOFILL® Regulatory Classification Matter
- NewsAvi Kapoor
Meta Posts Mixed Q2 Results, Joins Coursera, Qualcomm And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session
- News
MiMedx Group Q2 Adj. EPS $(0.05), Inline, Sales $64.362M Beat $63.460M Estimate
- Press releaseGlobe Newswire
MIMEDX Announces Second Quarter 2026 Operating & Financial Results
- Press releaseGlobe Newswire
MIMEDX to Acquire Sanara MedTech
- Press releaseGlobe Newswire
Regenerative Medicine's Next Chapter: Inside the Race to Make the Body Rebuild Itself
- Press releaseGlobe Newswire
The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It
- Press releaseGlobe Newswire
A Fresh FDA Catalyst Is Putting Regenerative Wound Care in Focus
- Press releasePRNewswire
The Body as Blueprint: A Recently Public Biotech Bets That Regrown Tissue Beats Replacement Parts
- Press releaseGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG
- Press releaseGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG
- News
CORRECTION: MiMedx Group Q1 Adj. EPS $(0.05) Misses $(0.03) Estimate, Sales $58.991M Miss $65.020M Estimate.
- Press releaseGlobe Newswire
MIMEDX Announces First Quarter 2026 Operating & Financial Results
- Press releaseGlobe Newswire
MIMEDX Announces Restructuring and Cost Reduction Initiative
- News
What to Expect from MiMedx Group's Earnings
- News
Beyond The Numbers: 4 Analysts Discuss MiMedx Group Stock
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- NewsAvi Kapoor
Why Versus Systems Shares Are Trading Higher By Around 71%; Here Are 20 Stocks Moving Premarket
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- Press releaseGlobe Newswire
MIMEDX Showcases Leading Allograft Portfolio and Its Latest Scientific and Clinical Evidence at SAWC Fall
- Press releasePRNewswire
EX-MiMEDX EMPLOYEES ALLEGE MiMEDX "PRESSURE[D] HEALTHCARE PROVIDERS TO TREAT WOUNDED VETERANS, DIABETICS, CHRONIC WOUND SUFFERERS, AND OTHER PATIENTS WITH MEDICALLY UNNECESSARY OR UNSUITABLE PRODUCTS"
- Press releasePRNewswire
THIRD DEFENDANT FIGHTS BACK AGAINST MiMEDX, CLAIMING 'DISREPUTABLE AND UNLAWFUL BUSINESS PRACTICES'
- Press releasePRNewswire
DEFENDANT FIGHTS BACK AGAINST MiMEDX "BLATANT INTIMIDATION" NON-COMPETE SUIT
- Press releaseGlobe Newswire
Cassava Sciences Announces Changes in Executive Leadership, Enhanced Corporate Governance and Other Initiatives
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.